Ulrike W. Kaunzner, MD, PhD
Assistant Professor, Neurology
Weill Cornell Medicine
Assistant Attending Neurologist
New York Presbyterian/Weill Cornell Medicine
New York, NY
Brian G. Weinshenker, MD, FRCP(C)
Consultant, Department of Neurology
Professor of Neurology
University of Virginia
NMO patient + Founder/Executive Director of
The Sumaira Foundation for NMO
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder (NMOSD).
This activity is intended to meet the educational needs of US-based neurologists, ophthalmologists, neuro-ophthalmologists, optometrists, pharmacists, emergency medicine clinicians, nurses, nurse practitioners, and physician assistants who diagnose and manage patients with NMOSD.
After completing in this educational initiative, clinicians should be better able to:
- Establish a diagnosis of NMOSD by using guideline-based and clinical criteria and differentiating it from other autoimmune disorders
- Compare and contrast the mechanisms of action, efficacy, safety, and tolerability of FDA-approved agents for NMOSD
- Leverage the patient’s symptoms, quality of life, comorbidities, and other factors to select NMOSD treatment for the best possible individualized outcomes
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with NMOSD.
CNE Credits: 1.25 ANCC Contact Hour(s).
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.25 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Dr. Weinshenker receives consulting fees from Alexion, Horizon, Genentech/Roche, UCB Biosciences and VielaBio. He receives royalty from RSR Ltd., and he is an Intellectual Property/Patent Holder for patent related to NMO-IgG for diagnosis of neuromyelitis optic spectrum disorder.
Dr. Kaunzner receives consulting fees from Genentech and serves on the ad boards for Novartis and Satralizumab. She reports a fellowship from the AAN in combination with Biogen and the American Brain Foundation.
Sumaira Ahmed has no relevant relationships to disclose.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Chris Drury, MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
- Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager has nothing to disclose.
- Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
- Naomi De Brito, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Submit the evaluation form to the Med Learning Group.
You will receive your certification as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.